Literature DB >> 8617968

Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines.

A Müller1, P J Rice, H E Ensley, P S Coogan, J H Kalbfleish, J L Kelley, E J Love, C A Portera, T Ha, I W Browder, D L Williams.   

Abstract

Glucan phosphate, a water-soluble, chemically defined (1-->3)-beta-D-glucan biologic response modifier, has been reported to exert antisepsis activity and accelerate wound healing. In this study we describe the specific binding of glucan phosphate to human and murine monocyte/macrophage cell lines, U937 and J774A.1, respectively. At 37 degrees C, equilibrium binding was rapidly achieved, i.e., within 1 min. In U937 cells, binding occurred with an affinity (Kd) of 37 microM and a Bmax of 65 x 106 binding sites/cell at 37 degrees C. In J774A.1 cells, glucan phosphate bound with an affinity (Kd) of 24 microM and a Bmax of 53 x 106 binding sites/cell at 37 degrees C. In both cases there was insignificant nonspecific binding. We further demonstrated that bound glucan phosphate cannot be displaced by a 50-fold excess of unlabeled ligand, suggesting internalization of glucan phosphate. Transmission electron microscopy showed significantly increased cytoplasmic vacuolization and significantly decreased mitotic activity in glucan phosphate-treated U937 cells compared with that in untreated cells. Pullulan, a random coil alpha-(1-->4)-(1-->6)-linked glucose polymer that served as a control, did not compete for the same binding site as glucan phosphate in either cell line, indicating the specificity of the binding site for (1-->3)-beta-D-glucans. We conclude that water-soluble pharmaceutical grade (1-->3)-beta-D-glucan phosphate specifically binds to and is internalized by U937 and J774A.1 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617968

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Effects of a lichen galactomannan and its vanadyl (IV) complex on peritoneal macrophages and leishmanicidal activity.

Authors:  Guilhermina R Noleto; Ana Lucia R Mercê; Marcello Iacomini; Philip A J Gorin; Vanete Thomaz Soccol; Maria Benigna M Oliveira
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

3.  Macrophage internalization of fungal beta-glucans is not necessary for initiation of related inflammatory responses.

Authors:  Frances McCann; Eva Carmona; Vishwajeet Puri; Richard E Pagano; Andrew H Limper
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation.

Authors:  Elio Cenci; Antonella Mencacci; Antonio Spreca; Claudia Montagnoli; Angela Bacci; Katia Perruccio; Andrea Velardi; Walter Magliani; Stefania Conti; Luciano Polonelli; Luigina Romani
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.

Authors:  D C Ifrim; J Quintin; L Meerstein-Kessel; T S Plantinga; L A B Joosten; J W M van der Meer; F L van de Veerdonk; M G Netea
Journal:  Clin Exp Immunol       Date:  2015-07-07       Impact factor: 4.330

6.  Normal human fibroblasts express pattern recognition receptors for fungal (1-->3)-beta-D-glucans.

Authors:  P Kougias; D Wei; P J Rice; H E Ensley; J Kalbfleisch; D L Williams; I W Browder
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Cellular and molecular mechanisms of fungal β-(1→6)-glucan in macrophages.

Authors:  Ilka Noss; Tammy R Ozment; Bridget M Graves; Michael D Kruppa; Peter J Rice; David L Williams
Journal:  Innate Immun       Date:  2015-07-23       Impact factor: 2.680

8.  Leukocyte Dectin-1 expression is differentially regulated in fungal versus polymicrobial sepsis.

Authors:  Tammy R Ozment-Skelton; Elizabeth A deFluiter; Tuanzhu Ha; Chuanfu Li; Bridget M Graves; Donald A Ferguson; John B Schweitzer; Johanna Preizsner; Gordon D Brown; Siamon Gordon; John H Kalbfleisch; David L Williams
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

9.  Candida albicans primes TLR cytokine responses through a Dectin-1/Raf-1-mediated pathway.

Authors:  Daniela C Ifrim; Leo A B Joosten; Bart-Jan Kullberg; Liesbeth Jacobs; Trees Jansen; David L Williams; Neil A R Gow; Jos W M van der Meer; Mihai G Netea; Jessica Quintin
Journal:  J Immunol       Date:  2013-03-08       Impact factor: 5.422

10.  Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients.

Authors:  Justin Digby; John Kalbfleisch; Andy Glenn; Angie Larsen; William Browder; David Williams
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.